# Paul M. Stewart

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-m-stewart/

## Facts

| Field | Value |
| --- | --- |
| Citations | 40,169 |
| Field | Hormonal Regulation and Hypertension |
| h-index | 103 |
| i10-index | 354 |
| Last Known Institution | Western University |
| OpenAlex ID | https://openalex.org/A5050877182 |
| ORCID iD | 0000-0002-1749-9640 |
| Works | 650 |

## Researcher papers

Showing 12 of 15.

- [The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline](https://scholariq.org/papers/the-diagnosis-of-cushing-s-syndrome-an-endocrine-society-clinical-practice/)
- [LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR](https://scholariq.org/papers/localisation-of-11-hydroxysteroid-dehydrogenase-tissue-specific-protector-of-the/)
- [Corticosteroid Insufficiency in Acutely Ill Patients](https://scholariq.org/papers/corticosteroid-insufficiency-in-acutely-ill-patients/)
- [11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response](https://scholariq.org/papers/11-hydroxysteroid-dehydrogenase-type-1-a-tissue-specific-regulator-of/)
- [Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant](https://scholariq.org/papers/treatment-of-acromegaly-with-the-growth-hormone-receptor-antagonist-pegvisomant/)
- [Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement](https://scholariq.org/papers/treatment-of-adrenocorticotropin-dependent-cushing-s-syndrome-a-consensus/)
- [Extrarenal Expression of 25-Hydroxyvitamin D<sub>3</sub>-1α-Hydroxylase<sup>1</sup>](https://scholariq.org/papers/extrarenal-expression-of-25-hydroxyvitamin-d-sub-3-sub-1-hydroxylase-sup-1-sup/)
- [Does central obesity reflect “Cushing's disease of the omentum”?](https://scholariq.org/papers/does-central-obesity-reflect-cushing-s-disease-of-the-omentum/)
- [Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist](https://scholariq.org/papers/long-term-treatment-of-acromegaly-with-pegvisomant-a-growth-hormone-receptor/)
- [Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors](https://scholariq.org/papers/urine-steroid-metabolomics-as-a-biomarker-tool-for-detecting-malignancy-in/)
- [Mortality in Patients with Pituitary Disease](https://scholariq.org/papers/mortality-in-patients-with-pituitary-disease/)
- [Growth Hormone and Pituitary Radiotherapy, But Not Serum Insulin-Like Growth Factor-I Concentrations, Predict Excess Mortality in Patients with Acromegaly](https://scholariq.org/papers/growth-hormone-and-pituitary-radiotherapy-but-not-serum-insulin-like-growth/)

## Researcher topics

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Adrenal Hormones and Disorders](https://scholariq.org/topics/adrenal-hormones-and-disorders/)
- [Pituitary Gland Disorders and Treatments](https://scholariq.org/topics/pituitary-gland-disorders-and-treatments/)
- [Growth Hormone and Insulin-like Growth Factors](https://scholariq.org/topics/growth-hormone-and-insulin-like-growth-factors/)
- [Adrenal and Paraganglionic Tumors](https://scholariq.org/topics/adrenal-and-paraganglionic-tumors/)

## Researcher university

- [Western University](https://scholariq.org/institutions/western-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.